MB-dNPM1-TCR.1 in Relapsed/Refractory AML

NCT06424340 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Miltenyi Biomedicine GmbH